Cellens
Latest round
- Seed
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 1
About Cellens
Based in Massachusetts, US, and founded in 2020 by Jonas Pirkl, and XueYing Wang, and Phuong Jean Pham (CEO), Cellens Inc. is a developer of cell fixation, sample processing, nanoimaging cell surface, and machine learning technology platform for bladder cancer detection. Cellens Inc. brings clarity and confidence to cancer detection through advanced nanoscale imaging and machine learning. The firm is actively collaborating with cancer clinics, health care professionals, and health insurance organizations.
Who invested in Cellens
1 investor across 2 rounds
See all investors in Cellens
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cellens
Who invested in Cellens?
Cellens has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellens raised?
Cellens has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cellens last raise money?
Cellens's most recent round on record is a Seed, in Aug 2025.
What does Cellens do?
Based in Massachusetts, US, and founded in 2020 by Jonas Pirkl, and XueYing Wang, and Phuong Jean Pham (CEO), Cellens Inc.
Where is Cellens headquartered?
Cellens is headquartered in US.
Which VCs invest in companies like Cellens?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Cellens's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Cellens? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.